MARKET WIRE NEWS

AIMIA CONFIRMS ELECTION OF DIRECTORS

Source: Canada Newswire

Canada NewsWire

TORONTO, May 14, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) announced today that all five nominees proposed for election to the Company's Board of Directors listed in its management information circular dated April 8, 2026 were elected at its Annual Meeting of Shareholders. The percentage of shares at the Meeting voting in favour of individual directors is as follows:

Director 

% of Votes For

% of Votes Against

Robert Feingold

93.38 %

6.62 %

Steven Leonard

93.25 %

6.75 %

Thomas Little

99.59 %

0.41 %

Muhammad Asif Seemab

99.43 %

0.57 %

Rhys Summerton

93.35 %

6.65 %

Shareholders voted to re-appoint PWC as Aimia's Auditors.

Management's approach to executive compensation ("Say on Pay") disclosed in Aimia's management information circular dated April 8, 2026 was approved with 98.26% of shares represented at the meeting voting in favour.

Aimia's full Report on Voting Results has been filed on SEDAR+ at www.sedarplus.ca

About Aimia
Aimia Inc. (TSX: AIM; JSE: AII) is a diversified conglomerate focused on enhancing the value of its holdings. Headquartered in Toronto, Aimia's priorities include increasing its intrinsic value, reducing holding company costs, reducing the discount of its share price to the intrinsic value of its businesses, and redeploying capital to make investments in undervalued companies.

For more information about Aimia, visit www.aimia.com.

SOURCE Aimia Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2026/14/c5205.html

AIM ImmunoTech Inc.

NASDAQ: AIM

AIM Trading

26.1% G/L:

$0.3232 Last:

66,112,703 Volume:

$0.2756 Open:

VWAV Ad 300

AIM Latest News

May 14, 2026 05:00:00 pm
AIMIA CONFIRMS ELECTION OF DIRECTORS

AIM Stock Data

$3,240,384
3,276,294
0.11%
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Ocala

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App